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Summary
Aim and objective: This study was aimed at comparing the arterial blood pressures in steady
state adult sickle cell patients with those of age- and sex-matched healthy controls.
Methods: A descriptive cross-sectional study of 62 sickle cell anemia patients and 62 age- and
sex-matched healthy controls was carried out in the adult outpatient sickle cell clinics and the
cardiac center of the University of Nigeria Teaching Hospital (UNTH), Enugu, Nigeria. Brachial
blood pressures were measured in the right arm in all subjects.
Results: Signiﬁcant increase in pulse rate was found in the study subjects (87.68± 8.91 bpm)
compared with the controls (72.13± 6.79 bpm) (p < 0.05). The mean systolic blood pressure
was comparable in the two groups. However, the patients had signiﬁcantly lower diastolic blood
pressure, lower mean arterial blood pressure, as well as a higher pulse pressure than the control
subjects. Signiﬁcant correlations were found between blood pressure indices and hematocrit,
body mass index, frequency of crisis, and body surface area.
Conclusion: Relatively lower arterial blood pressure is a signiﬁcant ﬁnding in patients with
sickle cell anemia. Hematocrit, frequency of crisis, body mass index, and body surface area are
signiﬁcant determinants of blood pressure indices in sickle cell anemia.
f Car© 2010 Japanese College ontroduction
rterial blood pressure has been reported to be typically
ow in sickle cell anemia and fails to show the age-related
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ise common in the normal population [1]. Johnson and Gior-
io [2] in a retrospective study in Los Angeles reported that
lood pressure in sickle cell patients was lower than it was in
ormal controls. This unusual blood pressure ﬁnding in sickle
ell anemia has been corroborated by reports from Grell et
l. [3] in Jamaica and De Jong et al. [4] in the Netherlands.
n a study of 64 adult sickle cell patients with normal creati-
ine levels by Grell et al. [3], systolic and diastolic pressures
ere 114± 11.0mmHg and 65.3± 5.3mmHg, respectively
Published by Elsevier Ireland Ltd. All rights reserved.
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(Arterial blood pressure in adult Nigerians with sickle cell an
compared with values in the controls of 144.1± 22.9mmHg
and 87.6± 13.8mmHg.
Although the exact mechanism of the lower blood
pressures is unknown, contributing factors could include
salt losing sickle cell nephropathy [5], a lowered periph-
eral resistance [6], alteration in circulating levels of
catecholamine, renin, aldosterone, and prostaglandin, or
changes in the sensitivity of receptors to these agents
[3].
As a group, patients with anemia have lower than
expected systolic and diastolic blood pressures [1,2]. How-
ever, it has been reported that the blood pressure in patients
with sickle cell disease is higher than expected given the
severity of their anemia, suggesting the possibility that they
have relative hypertension [7]. In a study of 89 sickle cell
patients, there was an association between higher blood
pressures and stroke. Survival decreased and the risk of
stroke increased as blood pressure rose, even though the
blood pressure at which these risks increased was below
the level deﬁning early hypertension in normal population
[7]. Stroke generally occurs in about 4.1% of patients with
sickle cell anemia [8]. However, the prevalence increases
to over 10% by the age of 50 years [8]. Cerebral ischemia
and infarction secondary to vaso-occlusion accounts for 80%
of cerebrovascular events [9]. The risk of vaso-occlusive
stroke increases with systolic blood pressure [1]. Intermit-
tent hypertension has been described during painful crisis
but the frequency or mechanism of this ﬁnding is unknown,
and hypertension with convulsions has occasionally followed
blood transfusions [10,11].
There are few data on this subject from the environment
of the study. This study was aimed at comparing the arterial
blood pressures in steady state adult sickle cell patients with
those of age- and sex-matched normal controls.
Methodology
A descriptive cross-sectional study of 62 sickle cell ane-
mia patients and 62 age- and sex-matched healthy controls
was carried out in the adult outpatient sickle cell clinics
and the cardiac center of the University of Nigeria Teaching
Hospital (UNTH), Enugu, Nigeria from February to August
2007. The study subjects were drawn from adult patients
(age ≥18 years) [12], attending the adult sickle cell clin-
ics of the UNTH Enugu, who had hemoglobin genotype SS
on hemoglobin electrophoresis, were in steady state, and
consented to participate in the study.
Steady state is deﬁned as absence of any crisis in the
preceding 4 weeks, and absence of any symptoms or signs
attributable to acute illness. The exclusion criteria for
patients were presence of congenital or acquired heart dis-
ease, pregnancy and/or inter-current illness, very severe
anemia (hematocrit <18%), excessive use of alcohol (more
than 16 g daily) [13], and use of tobacco. The controls were
healthy subjects selected from students and hospital work-
ers, as well as members of the local community. They were
age- and sex-matched with the patients. The eligibility cri-
teria for the controls were: HbAA genotype, absence of
congenital or acquired heart disease, consent to participate
in the study, absence of pregnancy and/or inter-current ill-
ness, and hematocrit level ≥30%. Ethical clearance for the
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tudy was obtained from the Ethical Committee of UNTH
nugu.
The weight and height of each subject were recorded
nd the surface area determined from a standard for-
ula [14]. The supine brachial and ankle blood pressures
ere measured separately with the cuff of the mercury
phygmomanometer applied to the right arm and right
alf, respectively. The approximate systolic blood pressures
ere obtained by palpation of the brachial artery. The
uff was deﬂated and re-inﬂated to about 10mmHg above
he approximate systolic value. Phases I and IV Korotkoff’s
ounds were used as systolic and diastolic blood pressure
eadings, respectively. The mean arterial blood pressure
as taken as the sum of the diastolic blood pressure and
ne-third of the pulse pressure. Hematological parameters
uch as hematocrit, reticulocyte count, white blood cell
ount with differentials, and hemoglobin electrophoresis
ere obtained.
Data are presented as means± standard deviation. In
rder to examine the effect of anemia on the variables,
he subjects were classiﬁed based on the hematocrit
alues into four classes in accordance with the World
ealth Organization classiﬁcation of anemia as follows:
lass 1, normal (hematocrit≥ 36%); Class 2, mild anemia
hematocrit 30—35.9%); Class 3, moderate anemia (hema-
ocrit 21—29.9%); and Class 4, severe anemia (hematocrit
8—20.9%) [15]. Inter-class differences in blood pressures
n the patients were compared by one-way analysis of vari-
nce and posthoc multiple comparison of mean using the
ukey’s honestly signiﬁcant difference test. Intra-class dif-
erences in parameters between patients and controls in the
ame hematocrit class were analyzed using the independent
tudent’s t-test. All statistical analyses were carried out
sing the Statistical Packages for Social Sciences (SPSS Inc.,
hicago, IL, USA) software version 11.0. Statistical tests with
robability values less than 0.05 were considered statisti-
ally signiﬁcant.
esults
aseline data
he mean ages for patients and controls were 28.27± 5.58
range 18—44) and 28.37± 5.91 (range 18—45) years, respec-
ively. There were no statistically signiﬁcant age and
ender differences in patients and controls. The study
ubjects had statistically signiﬁcant lower mean values
han controls in the measurement of height, weight,
ody mass index, and body surface area (p < 0.001)
Table 1).
ulse rate and brachial blood pressure
signiﬁcant increase in pulse rate was found in the study
ubjects (87.68± 8.91 bpm) compared with the controls
72.13± 6.79 bpm) (p < 0.05, Table 2). The mean systolic
lood pressure was comparable in the two groups. However,
he patients had signiﬁcantly lower diastolic blood pressure,
ower mean arterial blood pressure, as well as a higher pulse
ressure than the control subjects (Table 2). No signiﬁcant
ender differences in blood pressure indices were found.
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Table 1 Age, gender, and anthropometric data.
Parameters SCA Controls t-Test p-Value
Mean (SD) Mean (SD)
Age (years) 28.27 (5.58) 28.37 (5.91) 0.987 0.924
Gender [frequency (%)]
Male 31 (50) 31 (50) 0.000 1.00a
Female 31 (50) 31 (50)
Total 62 62
Weight (kg) 54.97 (10.61) 67.35 (8.37) 7.20 <.001*
Height (m) 1.62 (0.14) 1.72 (0.07) 4.960 <.001*
Body surface area (m2) 1.62 (0.03) 1.78 (0.14) 3.723 <.001*
Body mass index (kg/m2) 20.47 (2.73) 23.87 (3.22) 6.181 <.001*
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cSCA, sickle cell anemia.
* Statistically signiﬁcant.
a Chi-square.
ffects of hematocrit levels on physiologic
arameters in patients
able 3 compares the mean values for the physiologic param-
ters in the patients in the three separate categories (mild,
oderate, or severe anemia) based on their hematocrit lev-
ls using analysis of variance.
Signiﬁcant differences in mean values were observed in
rachial systolic blood pressures (F = 6.029; p = 0.004) and
ulse pressure (F = 5.747; p = 0.005).
Pair wise posthoc multiple comparison of mean using
ukey’s honestly signiﬁcant difference test showed that
he observed difference in systolic blood pressure was
ccounted for by the difference between the moderate
nd severe anemia group (SE = 3.7128; p = 0.006). The mean
ulse pressure for patients with mild anemia was sig-
iﬁcantly different from patients with moderate anemia
SE = 4.40621; p = 0.0013).
Comparison of blood pressure indices between patients
nd controls in the same hematocrit category (hematocrit
0—35.9%) showed no signiﬁcant difference in mean values
Table 4).
Correlation analysis of blood pressure indices and anthro-
ometric and physiologic variables in the patients showed
igniﬁcant correlations between: (1) systolic blood pres-
ure and hematocrit (r = 0.263; p = 0.039), weight (r = 0.448;
< 0.001), body mass index (r = 0.321; p = 0.011), body
urface area (r = 0.276; p = 0.03); (2) mean arterial pres-
ure and frequency of crisis (r = 0.267; p = 0.036); (3)
o
c
a
c
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Table 2 Physiologic data in patients and controls.
Parameters SCA
Mean (SD)
Pulse rate (bpm) 87.68 (8.91)
Brachial systolic BP (mmHg) 119.50 (11.70)
Brachial diastolic BP (mmHg) 64.867 (8.95)
Brachial pulse pressure (mmHg) 54.63 (12.87)
Mean brachial arterial BP (mmHg) 81.18 (12.65)
Hematocrit (%) 24.07 (3.10)
BP, blood pressure; SCA, sickle cell anemia.
* Statistically signiﬁcant.ulse pressure and weight (r = 0.331; p = 0.009). These
orrelation coefﬁcients remained statistically signiﬁcant
ven after controlling for the effect of hematocrit,
Tables 5 and 6).
iscussion
he brachial systolic blood pressure in sickle cell anemia
atients from this study was not signiﬁcantly different from
hat of the controls, but the diastolic blood pressure was
ound to be signiﬁcantly lower in the patients than in the
ontrols.
Ayuo et al. [16] reported similar ﬁndings in his study, in
enya, of 52 sickle cell anemia patients in steady state,
3—27 years of age (mean age 18.9 years) and mean
emoglobin concentration of 8.5± 1.4 g/dl; in which the sys-
olic blood pressure of 114.9± 9.9mmHg was found to be
omparable with that of the controls, while the diastolic
lood pressure of 64.6± 10mmHg was signiﬁcantly lower
han that of the controls. However Grell et al. [3] in a
tudy of 64 Jamaican sickle cell anemia patients with ages
anging from 30 to 69 years, reported statistically signiﬁ-
ant lower levels of systolic and diastolic blood pressures
f 114.6± 11.0mmHg and 65.3± 5.3mmHg, respectively
ompared with values in the controls of 144.1± 22.9mmHg
nd 87.6± 13.8mmHg. The mean ages and hemoglobin
oncentration were not speciﬁed. The apparent signiﬁ-
ant difference observed in the Jamaican study could be
Controls t-Test p-Value
Mean (SD)
72.13 (6.79) 11.062 <.001*
121.2 (8.97) 0.527 0.599
76.88 (6.18) 8.629 <.001*
44.31 (10.91) 4.735 0.001*
91.71 (5.47) 5.850 <.001*
38.65 (1.97) 30.589 <.001*
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Table 3 Physiologic parameters in sickle cell anemia; comparison with hematocrit levels.
Parameters Values; mean (SD) F-statistic p-Value
Hematocrit levels
Mild Moderate Severe
Age 26.11 (3.59) 23.60 (5.35) 25.18 (7.48) 0.922 0.402
Pulse rate 90.89 (13.57) 86.45 (8.36) 89.54 (5.54) 1.214 0.304
Brachial SBP 115.11 (13.57) 122.85 (9.34) 110.91 (13.75) 6.029 0.004*
Brachial DBP 69.78 (12.21) 64.60 (8.84) 61.87 (4.05) 2.083 0.134
Pulse pressure 45.33 (10.28) 58.25 (12.19) 49.09 (12.21) 5.747 0.005*
MAP 74.53 (28.58) 83.42 (6.82) 78.49 (6.39) 2.210 0.119
DBP, diastolic blood pressure; SBP, systolic blood pressure; MAP, mean arterial blood pressure.
* Statistically signiﬁcant.
Table 4 Comparison of age and blood pressure indices in subsets of patients and controls with hematocrit level between 30
and 35.9%.
Parameters Values; mean (SD) t-Test p-Value
SCA Controls
Age 26.11 (3.59) 22.82 (3.82) 1.972 0.064
Pulse rate 90.89 (13.57) 72.19 (5.33) 4.213 0.001*
Brachial SBP 115.11 (13.57) 124.55 (12.93) 1.588 0.130
Brachial DBP 69.78 (12.22) 78.18 (5.60) 2.043 0.056
Pulse pressure 45.33 (10.28) 46.36 (14.16) 0.182 0.857
MAP 74.53 (28.58) 92.73 (3.89) 2.101 0.056
SCA, sickle cell anemia; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure.
* Statistically signiﬁcant.
Table 5 Effect of clinical parameters on blood pressure indices in sickle cell anemia; a correlation analysis.
Clinical parameters Blood pressure indices
Systolic BP Diastolic BP MAP Pulse pressure Pulse rate
Hematocrit
r 0.263* 0.225 0.017 0.085 0.089
p 0.039 0.078 0.898 0.192 0.493
Frequency of crisis
r −0.121 −0.140 −0.267* −0.016 0.064
p 0.342 0.279 0.036 0.903 0.624
Weight
r 0.448* 0.114 0.230 0.331* −0.134
p <0.0001 0.378 0.072 0.009 0.298
BMI
r −0.321* 0.128 0.123 0.205 0.054
p 0.011 0.320 0.341 0.110 0.678
BSA
r 0.276* 0.144 0.226 0.153 −0.001
p 0.030 0.266 0.077 0.235 0.992
Age
r 0.099 0.056 0.037 0.099 0.118
p 0.445 0.664 0.775 0.444 0.361
Sex
r −0.087 0.137 0.149 −0.174 −0.159
p 0.501 0.289 0.549 0.176 0.218
BP, blood pressure; MAP, mean arterial pressure; BMI, body mass index; BSA, body surface area.
* Statistically signiﬁcant.
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Table 6 Partial correlation analysis of clinical parameters and blood pressure indices while controlling for the effect of
hematocrit in sickle cell anemia patients.
Clinical parameters Blood pressure indices
Systolic BP Diastolic BP MAP Pulse pressure Pulse rate
Age
r −0.076 0.035 0.036 0.043 −0.128
p 0.562 0.789 0.786 0.740 0.326
Sex
r −0.069 0.159 0.151 −0.169 0.167
p 0.596 0.222 0.245 0.194 0.199
Frequency of crisis
r −0.084 −0.107 −0.268* −0.002 0.079
p 0.520 0.412 0.037 0.988 0.543
BMI
r 0.259* 0.061 0.124 0.189 0.027
p 0.044 0.642 0.340 0.147 0.838
Weight
r 0.381* 0.012 0.250 0.329* −0.198
p 0.002 0.926 0.052 0.009 0.126
BSA
r 0.238 0.105 0.228 0.140 −0.019
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BP, blood pressure; MAP, mean arterial pressure; BMI, body mass i
* Statistically signiﬁcant.
ccounted for by the slightly elevated systolic blood pres-
ures in the controls.
We observed higher systolic blood pressure and pulse
ressure in sickle cell anemia patients with moderate ane-
ia when compared to patients with severe anemia. Several
actors could contribute to this effect. Firstly, the com-
ined effect of certain variables in the patients on blood
ressure parameters could be quite signiﬁcant. This study
dentiﬁed some factors that might be determinants of blood
ressure indices in sickle cell anemia. These include fre-
uency of crises, weight, body mass index, body surface
rea, as well as following blood transfusion [10,11,17]. How-
ver, the extent to which these factors affect blood pressure
ndices is yet to be determined. Secondly, the circulatory
esponse to anemia with resultant reduced peripheral vascu-
ar resistance and fall in blood pressure is more pronounced
n patients with severe anemia.
Our ﬁnding of signiﬁcantly increased pulse rate in the
atients when compared with the controls in the same
ematocrit category may be related to the increased back-
round inﬂammatory and oxidative stress associated with
ickle cell anemia [18]. Besides, it is likely that the sickle
ell anemia patients had a signiﬁcant variable severity of
nemia which may not be properly represented by a single
ematocrit measure as used for data analysis in this study.
We noted signiﬁcant correlations between blood pres-
ure indices and hematocrit, body mass index, frequency
f crisis, and body surface area. After controlling for the
ffect of anemia (hematocrit) signiﬁcant correlations were
till observed in the last three variables. These results con-
rm previous ﬁndings by Pegelow et al. [1] who reported
igniﬁcant correlation between blood pressure indices and
ody mass index, hematocrit, renal function, age, and sex.
owever, our study did not demonstrate any signiﬁcant cor-0.078 0.283 0.885
; BSA, body surface area.
elation of blood pressure with age or sex probably due to
he preponderance of younger subjects in this study. Sickle
ell anemia patients with frequent crisis and increased
yper-hemolysis states have been found to have increased
revalence of elevated systolic blood pressure and pul-
onary hypertension [19].
The signiﬁcantly lower diastolic blood pressure and
ncreased pulse pressure noted in the patients in this study
ould be as a result of the hemodynamic circulation from
hronic anemia, since these differences were not observed
hen the effect of anemia was accounted for by com-
aring patients and controls with mild anemia (hematocrit
0—35.9%).
However, increased pulse pressure has been shown to
redict cardiac morbidity in studies carried out in diabetic
nd hypertensive patients [20,21]. Its relevance in patients
ith sickle cell anemia is yet to be explored.
In conclusion, our ﬁndings support previous reports of rel-
tively lower arterial blood pressure in patients with sickle
ell anemia. Hematocrit, frequency of crisis, body mass
ndex, and body surface area are signiﬁcant determinants
f blood pressure indices in sickle cell anemia. Blood pres-
ure in these patients should be evaluated relative to the
ower values expected for patients with sickle cell ane-
ia.
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